SCHEMBL1615740

SCHEMBL1615740

c1ccc2c(c1)CC[C@H]2Nc1ccc2c(Nc3cccc4cc[nH]c34)cccc2n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 3/20 0.39
GBA1 P04062 1/20 0.39
DDB1 Q16531 1/20 0.38
CRBN Q96SW2 1/20 0.38
HDAC6 Q9UBN7 1/20 0.37
KCNN3 Q9UGI6 1/20 0.37
JAK2 O60674 3/20 0.36
JAK1 P23458 1/20 0.36
TYK2 P29597 1/20 0.36
JAK3 P52333 1/20 0.36
CDK1 P06493 1/20 0.36
LYN P07948 2/20 0.36
ZAP70 P43403 2/20 0.36
RET P07949 1/20 0.36
FLT3 P36888 1/20 0.36
ALK Q9UM73 1/20 0.36
IGF1R P08069 1/20 0.35
FADS1 O60427 1/20 0.35
PARP1 P09874 2/20 0.35
EGFR P00533 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1616399 0.88 HDAC6 (0.43) SYKGBA1DDB1CRBNHDAC6
SCHEMBL1616700 0.84 CDK1 (0.44) GBA1DDB1CRBNHDAC6KCNN3
SCHEMBL1616741 0.83 CDK1 (0.42) GBA1HDAC6KCNN3JAK2JAK1
SCHEMBL3844986 0.80 PDPK1 (0.47) GBA1DDB1CRBNHDAC6KCNN3
SCHEMBL1616678 0.79 FADS1 (0.47) GBA1HDAC6KCNN3JAK2JAK1
SCHEMBL1615579 0.79 PFKFB3 (0.42) GBA1HDAC6KCNN3FADS1PFKFB3
SCHEMBL1616344 0.78 GBA1 (0.46) GBA1DDB1CRBNHDAC6KCNN3
SCHEMBL1616343 0.78 GBA1 (0.46) GBA1DDB1CRBNHDAC6KCNN3
SCHEMBL2245619 0.77 GBA1 (0.47) GBA1DDB1CRBNHDAC6KCNN3
SCHEMBL1616633 0.77 HDAC6 (0.43) GBA1DDB1CRBNHDAC6KCNN3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7923561-B2 Quinolines HOFFMANN-LA ROCHE INC. (US) 2011-04-12 US claimed
EP-2099763-B1 2-AMINOQUINOLINES AS 5-HT(5A) RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2010-08-11 EP claimed
EP-2099763-A1 2-AMINOQUINOLINES AS 5-HT(5A) RECEPTOR ANTAGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2009-09-16 EP claimed
US-20080146567-A1 QUINOLINES F. HOFFMANN-LA ROCHE AG (CH) 2008-06-19 US claimed
WO-2008068157-A1 2-AMINOQUINOLINES AS 5-HT(5A) RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2008-06-12 WO claimed
US-7923561-B2 Quinolines HOFFMANN-LA ROCHE INC. (US) 2011-04-12 US disclosed
EP-2099763-B1 2-AMINOQUINOLINES AS 5-HT(5A) RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2010-08-11 EP disclosed
EP-2099763-A1 2-AMINOQUINOLINES AS 5-HT(5A) RECEPTOR ANTAGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2009-09-16 EP disclosed
US-20080146567-A1 QUINOLINES F. HOFFMANN-LA ROCHE AG (CH) 2008-06-19 US disclosed
WO-2008068157-A1 2-AMINOQUINOLINES AS 5-HT(5A) RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2008-06-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080146567-A1 QUINOLINES HTR5A, HTR2B, HTR2C SYK 2576/4885GBA1 662/4885DDB1 2267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.